Skip to main content

Non-cirrhotic Intrahepatic Portal Hypertension: Associated Gut Diseases and Prognostic Factors

Digestive Diseases and Sciences volume 56, pages 227–235 (2011)Cite this article

Abstract

Background/Aims

Non-cirrhotic intrahepatic portal hypertension (NCIPH) is generally regarded to have a benign prognosis. We have studied a cohort followed-up at a tertiary referral center and postulate that gut-derived prothrombotic factors may contribute to the pathogenesis and prognosis of NCIPH.

Methods

We retrospectively analyzed prognostic indicators in 34 NCIPH patients. We also searched for associated gut diseases.

Results

Transplant-free survival in NCIPH patients from first presentation with NCIPH at 1, 5, and 10 years was 94% (SE: 4.2%), 84% (6.6%), and 69% (9.8%), respectively. Decompensated liver disease occurred in 53% of patients. Three (9%) patients had ulcerative colitis while five of 31 (16%) tested had celiac disease and on Kaplan–Meier analysis, celiac disease predicted reduced transplant-free survival (p = 0.018). On multivariable Cox regression analysis, independent predictors of reduced transplant-free survival were older age at first presentation with NCIPH, hepatic encephalopathy, and portal vein thrombosis. Prevalence of elevated initial serum IgA anticardiolipin antibody (CLPA) was significantly higher in NCIPH (36% of patients tested), compared to Budd–Chiari syndrome (6%) (p = 0.032, Fisher’s exact test) and celiac disease without concomitant liver disease (0%) (p = 0.007).

Conclusions

We have identified prognostic factors and report progression to liver failure in 53% of NCIPH patients followed-up at our center. Our data supports a role for intestinal disease in the pathogenesis of intrahepatic portal vein occlusion leading to NCIPH.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl. 2005;6:627–634.

    Article  Google Scholar 

  2. Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut. 2002;2:275–280.

    Article  Google Scholar 

  3. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol. 2002;5:526–534.

    Article  Google Scholar 

  4. Henderson JM. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl. 2005;6:610–611.

    Article  Google Scholar 

  5. Boyer JL, Hales MR, Klatskin G. “Idiopathic” portal hypertension due to occlusion of intrahepatic portal veins by organized thrombi. A study based on postmortem vinylite-injection corrosion and dissection of the intrahepatic vasculature in 4 cases. Medicine (Baltimore). 1974;1:77–91.

    Google Scholar 

  6. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine (Baltimore). 1980;5:367–379.

    Google Scholar 

  7. Kingham JG, Levison DA, Stansfeld AG, Dawson AM. Non-cirrhotic intrahepatic portal hypertension: a long-term follow-up study. Q J Med. 1981;199:259–268.

    Google Scholar 

  8. Nakanuma Y, Hoso M, Sasaki M, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology. 1996;3:195–204.

    Article  Google Scholar 

  9. Austin A, Campbell E, Lane P, Elias E. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody. Gut. 2004;7:1032–1034.

    Article  Google Scholar 

  10. Sawada S, Sato Y, Aoyama H, Harada K, Nakanuma Y. Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of annuals of pathological autopsy cases in Japan. J Gastroenterol Hepatol. 2007;22(2):204–209.

    Article  PubMed  Google Scholar 

  11. Dhiman RK, Chawla Y, Vasishta RK, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol. 2002;1:6–16.

    Article  Google Scholar 

  12. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology. 1995;5:1238–1247.

    Google Scholar 

  13. Sarin SK, Sethi KK, Nanda R. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut. 1987;3:260–266.

    Article  Google Scholar 

  14. Hagiwara C, Tanaka M, Kudo H. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol. 2002;7:758–764.

    Article  Google Scholar 

  15. Cancado EL, Medeiros DM, Deguti MM, et al. Celiac disease associated with nodular regenerative hyperplasia, pulmonary abnormalities, and IgA anticardiolipin antibodies. J Clin Gastroenterol. 2006;2:135–139.

    Article  Google Scholar 

  16. Ross AG, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med. 2002;346:1212–1220. Review.

    Article  PubMed  Google Scholar 

  17. Mazumder DN. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol Appl Pharmacol. 2005;206:169–175.

    Article  PubMed  Google Scholar 

  18. Nevens F, Fevery J, Van Steenbergen W, Sciot R, Desmet V, De Groote J. Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol. 1990;11:80–85.

    CAS  Article  PubMed  Google Scholar 

  19. Geubel AP, De Galocsy C, Alves N, Rahier J, Dive C. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology. 1991;100:1701–1709.

    CAS  PubMed  Google Scholar 

  20. Daniel F, Cadranel JF, Seksik P, et al. Azathioprine induced nodular regenerative hyperplasia in IBD patients. Gastroenterol Clin Biol. 2005;29:600–603.

    Article  PubMed  Google Scholar 

  21. Ravikumara M, Hill FG, Wilson D, et al. C6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia–a dual-centre experience. J Pediatr Gastroenterol Nutr. 2006;42:535–538.

    CAS  Article  PubMed  Google Scholar 

  22. de Boer NK, Reinisch W, Teml A, Dutch 6-TG working group, et al. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party. Digestion. 2006;73:25–31. Epub 2006 Feb 21. Review.

    Article  PubMed  Google Scholar 

  23. Perez Ruiz F, Orte Martinez FJ, Zea Mendoza AC, Ruiz del Arbol L, Moreno Caparros A. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin Arthritis Rheum. 1991;21:47–54. Review.

    CAS  Article  PubMed  Google Scholar 

  24. Ward C, Lucas M, Piris J, Collier J, Chapel H. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol. 2008;153:331–337. Epub 2008 Jul 18.

    CAS  Article  PubMed  Google Scholar 

  25. Malamut G, Ziol M, Suarez F, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol. 2008;48:74–82. Epub 2007 Oct 17.

    Article  PubMed  Google Scholar 

  26. Wanless IR, Peterson P, Das A, Boitnott JK, Moore GW, Bernier V. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology. 1990;12:1166–1174.

    CAS  Article  PubMed  Google Scholar 

  27. Madhu K, Ramakrishna B, Zachariah U, Eapen CE, Kurian G. Non-cirrhotic intrahepatic portal hypertension. Gut. 2008;57:1529.

    CAS  Article  PubMed  Google Scholar 

  28. Roskams T, Baptista A, Bianchi L, et al. Histopathology of portal hypertension: a practical guideline. Histopathology. 2003;42(1):2–13. Review.

    CAS  Article  PubMed  Google Scholar 

  29. Madhu K, Avinash B, Ramakrishna B, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension: common cause of cryptogenic intrahepatic portal hypertension in a Southern Indian tertiary hospital. Indian J Gastroenterol. 2009;28:83–87. Epub 2009 Nov 12.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Dr C. E. Eapen was supported by a Sheila Sherlock Fellowship awarded by the European Association for the Study of the Liver for 2004.

Author information

Author notes

  1. C. E. Eapen

    Present address: Department of GI Sciences, Liver Unit, Christian Medical College, Vellore, Tamil Nadu, 632004, India

  2. Dimitris Velissaris

    Present address: Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Patras, 26500, Rion, Greece

Affiliations

  1. Liver Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK

    C. E. Eapen, Dimitris Velissaris & Elwyn Elias

  2. Wellcome Trust Clinical Research Facility, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK

    Peter Nightingale

  3. Department of Pathology, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK

    Stefan G. Hubscher

  4. Clinical Immunology, Division of Immunology and Infection, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK

    Peter J. Lane

  5. Department of Immunology, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK

    Timothy Plant

Authors
  1. C. E. Eapen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Nightingale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan G. Hubscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter J. Lane
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Timothy Plant
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dimitris Velissaris
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elwyn Elias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elwyn Elias.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Eapen, C.E., Nightingale, P., Hubscher, S.G. et al. Non-cirrhotic Intrahepatic Portal Hypertension: Associated Gut Diseases and Prognostic Factors. Dig Dis Sci 56, 227–235 (2011). https://doi.org/10.1007/s10620-010-1278-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-010-1278-2

Keywords

  • Non-cirrhotic portal hypertension
  • Celiac disease
  • Inflammatory bowel disease
  • IgA cardiolipin antibody
  • Portal vein thrombosis